NCT03917953

Brief Summary

RATIONALE: Transcutaneous electrical acupoint stimulation may improve attention deficit hyperactivity disorder (ADHD). PURPOSE: This randomized-controlled trial study of treating attention deficit hyperactivity disorder of school-aged children with transcutaneous electrical acupoint stimulation to see how well it works compared to sham transcutaneous electrical acupoint stimulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 17, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2020

Completed
Last Updated

March 15, 2021

Status Verified

February 1, 2021

Enrollment Period

5 months

First QC Date

April 14, 2019

Last Update Submit

March 11, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • the investigator-rated Clinical Global Impression-Improvement (CGI-I) scores

    The CGI-Improvement scale was used to evaluate the improvement, maintenance, or worsening of subjects' symptoms compared to baseline. The CGI-Improvement Scale includes seven options for scoring: 1 very much improved; 2 much improved; 3 minimally improved; 4 no change; 5 minimally worse; 6 much worse; and 7 very much worse. Clinical response at week 4 was defined as a rating of "much" or "very much improved" (1 or 2), which is considered a clinically meaningful response.

    4 weeks

Secondary Outcomes (5)

  • Clinical Global Impression-Improvement-Severity (CGI-S) score

    4 weeks

  • Conners' Parent Rating Scales-Revised: Short Form (CPRS-R: S) score

    4 weeks

  • Conners' Teacher Rating Scales-Revised: Short Form (CTRS-R: S) score

    4 weeks

  • go/no-go task performances

    4 weeks

  • the concentration of oxygenated hemoglobin within the prefrontal cortex

    4 weeks

Study Arms (2)

Arm I

EXPERIMENTAL

Patients receive transcutaneous electrical acupoint stimulation therapy twice weekly for 4 weeks.

Device: Transcutaneous Electrical Acupoint Stimulation

Arm II

SHAM COMPARATOR

Patients receive sham transcutaneous electrical acupoint stimulation therapy twice weekly for 4 weeks.

Device: Transcutaneous Electrical Acupoint Stimulation

Interventions

Patients in the experimental group will be treated for 20 min TEAS, twice a week, for a total of 4 weeks of treatment.The same intervention was performed in the sham group (electrode patches were attached at corresponding acupoints without electrical stimulation). Acupoint selection: baihui (GV 20), taichong (LR 3), taixi (KI 3).

Arm IArm II

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients must be conform to ADHD clinical diagnostic criteria (DSM-V).
  • Patients' ages are between 6\~12 years old.
  • An informed written consent from parents and participants

You may not qualify if:

  • Patients have a history of illness that concomitant with other mental and neurological disorders.
  • Patients's IQ score are lower than 75.
  • Patients have had prior TEAS or other acupoints-associated treatment experiences.
  • Left handedness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xian Children's Hospital

Xi'an, Shaanxi, 710000, China

Location

Related Publications (5)

  • Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016 Mar 19;387(10024):1240-50. doi: 10.1016/S0140-6736(15)00238-X. Epub 2015 Sep 17.

    PMID: 26386541BACKGROUND
  • Lee MS, Choi TY, Kim JI, Kim L, Ernst E. Acupuncture for treating attention deficit hyperactivity disorder: a systematic review and meta-analysis. Chin J Integr Med. 2011 Apr;17(4):257-60. doi: 10.1007/s11655-011-0701-7. Epub 2011 Apr 21.

    PMID: 21509667BACKGROUND
  • Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L, Li N, Lu Y, Su T, Sun J, Wang J, Yue Z, Zhang W, Zhao J, Zhou Z, Wu J, Zhou K, Ai Y, Zhou J, Pang R, Wang Y, Qin Z, Yan S, Li H, Luo L, Liu B. Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial. JAMA. 2017 Jun 27;317(24):2493-2501. doi: 10.1001/jama.2017.7220.

    PMID: 28655016BACKGROUND
  • Liu Z, Yan S, Wu J, He L, Li N, Dong G, Fang J, Fu W, Fu L, Sun J, Wang L, Wang S, Yang J, Zhang H, Zhang J, Zhao J, Zhou W, Zhou Z, Ai Y, Zhou K, Liu J, Xu H, Cai Y, Liu B. Acupuncture for Chronic Severe Functional Constipation: A Randomized Trial. Ann Intern Med. 2016 Dec 6;165(11):761-769. doi: 10.7326/M15-3118. Epub 2016 Sep 13.

    PMID: 27618593BACKGROUND
  • Zhuo L, Zhao X, Zhai Y, Zhao B, Tian L, Zhang Y, Wang X, Zhang T, Gan X, Yang C, Wang W, Gao W, Wang Q, Rohde LA, Zhang J, Li Y. Transcutaneous electrical acupoint stimulation for children with attention-deficit/hyperactivity disorder: a randomized clinical trial. Transl Psychiatry. 2022 Apr 21;12(1):165. doi: 10.1038/s41398-022-01914-0.

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Yan Li, Dr.

    First Afflicated Hospital Xian Jiaotong University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Children with ADHD in the 2 groups were treated in separate treatment rooms and blinded on the intervention (i.e., true or sham TEAS). The TEAS operators could not be blinded to the treatment assignments. The data collectors, outcome assessors, and statisticians were blinded to group allocations.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2019

First Posted

April 17, 2019

Study Start

July 1, 2019

Primary Completion

December 1, 2019

Study Completion

January 17, 2020

Last Updated

March 15, 2021

Record last verified: 2021-02

Locations